Skip to main content
logo
Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.570
-0.020 (-0.56%)
At close: Sep 1, 2026, 4:00 PM EDT
3.540
-0.030 (-0.84%)
After-hours: Sep 1, 2026, 7:47 PM EDT

Prime Medicine Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6356143738171,609-
Market Cap Growth
15.97%64.88%-54.41%-49.22%--
Enterprise Value
6535192386691,890-
Last Close Price
3.573.472.928.8618.58-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
155.93132.63124.90---
PB Ratio
15.905.082.436.145.09-
P/TBV Ratio
15.955.082.436.145.09-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
160.21112.0879.89---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
2.830.960.270.100.090.04
Net Debt / Equity Ratio
0.44-0.51-0.98-0.81-0.84-1.08
Net Debt / EBITDA Ratio
-0.090.310.760.582.323.09
Net Debt / FCF Ratio
-0.110.371.150.621.796.78
Asset Turnover
0.020.010.01---
Quick Ratio
3.004.755.022.1611.004.65
Current Ratio
3.064.845.582.5311.104.67
Return on Equity (ROE)
-373.29%-146.81%-136.88%-88.19%-43.83%-121.13%
Return on Assets (ROA)
-46.52%-40.68%-51.51%-43.15%-22.00%-29.61%
Return on Capital Employed (ROCE)
-90.40%-68.20%-78.00%-139.20%-34.90%-34.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-29.58%-32.74%-52.58%-24.25%-7.57%-
FCF Yield
-24.70%-27.20%-34.94%-21.31%-9.19%-
Buyback Yield / Dilution
-36.41%-25.43%-30.37%-168.41%-161.23%-391.47%
SEC Filings: 10-K · 10-Q